Daily Archive: February 8, 2012

About the Alzheimer’s Drug Discovery Foundation (ADDF)

Figure 1: ADDF funding priorities The ADDF specifically funds drug discovery programs from the stage of screening through to phase II clinical trial, in the field of Alzheimer’s disease and related dementias. ADDF funding takes risk, bridging the gap between government funding of basic research and later stage investment during clinical trials.

      MISSION The Alzheimer’s Drug Discovery Foundation (ADDF) is a non-for-profit organization that provides funding for drug discovery and development research programs in the field of Alzheimer’s disease (AD), related dementias and cognitive aging.  The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by …

Continue reading »